189 related articles for article (PubMed ID: 16953231)
1. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q
Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231
[TBL] [Abstract][Full Text] [Related]
2. Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44.
Hartmann M; Parra LM; Ruschel A; Böhme S; Li Y; Morrison H; Herrlich A; Herrlich P
Mol Cancer Res; 2015 May; 13(5):879-90. PubMed ID: 25652588
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
[TBL] [Abstract][Full Text] [Related]
4. Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin.
Ma J; Klemm J; Gerardo-Ramírez M; Frappart L; Castven D; Becker D; Zoch A; Parent R; Bartosch B; Minnich K; Giovannini M; Danckwardt S; Hartmann N; Morrison H; Herrlich P; Marquardt JU; Hartmann M
Int J Cancer; 2020 Nov; 147(9):2564-2577. PubMed ID: 32525563
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
6. Deletion of
Gerardo-Ramírez M; Giam V; Becker D; Groth M; Hartmann N; Morrison H; May-Simera HL; Radsak MP; Marquardt JU; Galle PR; Herrlich P; Straub BK; Hartmann M
Cells; 2023 Apr; 12(9):. PubMed ID: 37174657
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
9. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
10. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.
Morrison H; Sherman LS; Legg J; Banine F; Isacke C; Haipek CA; Gutmann DH; Ponta H; Herrlich P
Genes Dev; 2001 Apr; 15(8):968-80. PubMed ID: 11316791
[TBL] [Abstract][Full Text] [Related]
11. Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.
Stamenkovic I; Yu Q
Curr Protein Pept Sci; 2010 Sep; 11(6):471-84. PubMed ID: 20491622
[TBL] [Abstract][Full Text] [Related]
12. Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.
Ahmad Z; Brown CM; Patel AK; Ryan AF; Ongkeko R; Doherty JK
Otol Neurotol; 2010 Apr; 31(3):460-6. PubMed ID: 20195187
[TBL] [Abstract][Full Text] [Related]
13. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
14. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
15. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
[TBL] [Abstract][Full Text] [Related]
16. The merlin interacting proteins reveal multiple targets for NF2 therapy.
Scoles DR
Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
[TBL] [Abstract][Full Text] [Related]
17. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
18. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation.
Sun CX; Robb VA; Gutmann DH
J Cell Sci; 2002 Nov; 115(Pt 21):3991-4000. PubMed ID: 12356905
[TBL] [Abstract][Full Text] [Related]
19. Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing.
Cole BK; Curto M; Chan AW; McClatchey AI
Mol Cell Biol; 2008 Feb; 28(4):1274-84. PubMed ID: 18086884
[TBL] [Abstract][Full Text] [Related]
20. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]